Skip to main content

Postherpetic Neuralgia: Difficult to Treat, Easier to Prevent

  • Chapter
  • First Online:
Herpes Zoster: Postherpetic Neuralgia and Other Complications
  • 1473 Accesses

Abstract

The first quotation describes the situation as the virus lies dormant and asymptomatic and difficult to detect but likely easier to prevent by vaccination, whereas later with the eruption of the characteristic painful rash of herpes zoster (HZ), it becomes easy to diagnose but difficult to treat.

For it happens…in the beginning the malady is easy to cure but difficult to detect but in time, not having been detected or treated, it becomes easy to detect but difficult to cure.

Nicola Machiavelli, The Prince

A kindly understanding doctor who will keep in touch with his patients with intractable postherpetic neuralgia even for a very long time is extremely valuable therapeutically.

Edgar Hope-Simpson [25]

The efficient physician is he who amuses his patients while nature effects a cure.

The philosophical dictionary, Voltaire (1694–1778)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Attal N, Cruccu G, Baron R et al (2010) EFNS guidelines on the pharmacological treatment of neuropathic pain: revision. Eur J Neurol 17:1113–1123

    Article  CAS  PubMed  Google Scholar 

  2. Backonja MD, Wallace MS, Bionski ER et al (2008) NGX-4010, a high concentration capsaicin patch for the treatment of postherpetic neuralgia: a randomized , double-blind study. Lancet Neurol 7(12):1106–1112

    Article  CAS  PubMed  Google Scholar 

  3. Bowsher D (1996) Postherpetic neuralgia and its treatment: a retrospective survey of 191 patients. J Pain Symptom Manage 12:327–331

    Article  Google Scholar 

  4. Brisson M, Pellisier JM, Camden S, Quach C, DeWals S (2008) The potential cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia. Hum Vaccin 4:238–245

    Article  PubMed  Google Scholar 

  5. Capsaicin patch for postherpetic neuralgia (2011) The Medical Letter 53(Issue 1365):42–43

    Google Scholar 

  6. Chen N, Qifu L, Yang J (2014) Antiviral treatment for preventing postherpetic neuralgia, The Cochrane Collaboration.

    Google Scholar 

  7. Collins SL, Moore RA, McQuay HJ (2000) Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. J Pain Symptom Manage 20:449–458

    Article  CAS  PubMed  Google Scholar 

  8. Cook RJ, Sackett DL (1995) The number needed to treat: a clinically useful measure of treatment effect. Br Med J ;310:452–454 (review). The Cochrane Collaboration

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Coplan PM, Schmader K, Nikas A (2004) Development of a measure of burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials; adaptation of the brief pain inventory. J Pain 5:344–356

    Article  PubMed  Google Scholar 

  10. Demoragas JM, Kierland RR (1957) The outcome of patients with herpes zoster. Arch Dermatol 75:193–119

    Article  CAS  Google Scholar 

  11. Donahue JG, Choo PW, Manson JG et al (1995) The incidence of herpes zoster. Arch Intern Med 155:1605–1609

    Article  CAS  PubMed  Google Scholar 

  12. Drolet M, Brisson M et al (2010) A prospective study of the herpes zoster severity of illness. Clin J Pain 26:656–666

    PubMed  Google Scholar 

  13. Drolet M, Brisson M, Schmader K et al (2010) Predictors of postherpetic neuralgia among patients with herpes zoster :a prospective study. J Pain 11:1211–1221

    Article  PubMed  Google Scholar 

  14. Dworkin RH, Corbin AE, Young JP et al (2003) Pregabalin for the treatment of postherpetic neuralgia; a randomized placebo-controlled trial. Neurology 60(8):1274–1283

    Article  CAS  PubMed  Google Scholar 

  15. Dworkin RH, O’Connor AB, Backonja M et al (2007) Pharmacologic management of neuropathic pain:evidence-based recommendations. Pain 132:237–251

    Article  CAS  PubMed  Google Scholar 

  16. Dworkin RH, O’Connor AB, Audette J et al (2010) Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 85(3 suppl):S3–S14

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Dworkin RH, O’Connor AB, Backonja M et al (2007) Pharmacologic management of neuropathic pain:evidence-based recommendations. Pain 132:237–251

    Article  CAS  PubMed  Google Scholar 

  18. Dworkin RH, O’Connor AB, Audette J et al (2010) Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 85(3 suppl):S3–S14

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Finnerup NNB, Sindrup SH, Jensen TS (2010) The evidence for pharmacological treatment of neuropathic pain. Pain 150:573–581

    Article  PubMed  Google Scholar 

  20. Frieden TR, Houry D (2016) Reducing the risks of relief- the CDC opioid- prescribing guideline. N Engl J Med 374:1501–1504

    Article  Google Scholar 

  21. Gauthier A, Breuer J, Carrington D (2009) Epidemiology and cost of herpes zoster and postherpetic neuralgia in the United Kingdom. Epidemiol Infect 137:38–47

    Article  CAS  PubMed  Google Scholar 

  22. Gilron I, Watson CPN, Cahill CM, Moulin DE (2006) Neuropathic pain: a practical guide for the clinician. CMAJ 175(3):265–275

    Article  PubMed  PubMed Central  Google Scholar 

  23. Head H, Campbell AW (1900) The pathology of herpes zoster and its bearing on sensory localization. Brain 23:353–523

    Article  Google Scholar 

  24. Hope-Simpson RE (1965) The nature of herpes zoster: a long term study and a new hypothesis. Proc R Soc Med 58:9–20

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Hope-Simpson RE (2001) Some early investigations into the nature of herpes zoster and postherpetic neuralgia. In: Watson CPN, Gershon AA (eds) Herpes Zoster and postherpetic neuralgia, 2nd revised and enlarged edition. Elsevier, pp 1–12

    Google Scholar 

  26. Insinga DRP, Itzler RF, Pellisier JM et al (2005) The incidence of herpes zoster in a US administrative database. J Intern Med 20(8):748–783

    Google Scholar 

  27. Irving G, Jensen M, Cramer M (2009) Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia. Clin J Pain 25:185–192

    Article  PubMed  Google Scholar 

  28. Johnson RW, Rice ASC (2014) Postherpetic neuralgia. N Engl J Med 371(16):1526–1532

    Article  CAS  PubMed  Google Scholar 

  29. Kajdasz DK, Iyengar S, Desaiah D et al (2007) Duloxetine for the management of diabetic painful neuropathic pain:evidence-based findings from post-hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel group studies. Clin Ther 29:2536–2546

    Article  CAS  PubMed  Google Scholar 

  30. Kurzke JR (1984) Neuroepidemiology. Ann Neurol 16:265–277

    Article  Google Scholar 

  31. Lal H et al (2015) Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med 372:2087–2096

    Article  PubMed  Google Scholar 

  32. Lunn MPT, Hughes RAC, Wiffen PJ (2009) Duloxetine for treating painful neuropathy or chronic pain (Review) The Cochrane Collaboration Issue (4):CD007115

    Google Scholar 

  33. Morrison V, Johnson GR, Schmader KE (2015) Long-term persistence of zoster vaccine efficacy. CID 60:900–909

    Article  Google Scholar 

  34. Moulin DE, Clark AJ, Gilron I et al (2007) Pharmacological management of chronic neuropathic pain-Consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 12:13–21

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Noordenbos W (1959) PAIN: problems pertaining to the transmission of nerve impulses which give rise to pain. Elsevier

    Google Scholar 

  36. Oaklander AL, Romans K, Horasdek S (1998) Unilateral postherpetic neuralgia is associated with bilateral sensory change. Ann Neurol 44:789–795

    Article  CAS  PubMed  Google Scholar 

  37. Oxman MN, Levin MD, Johnson JR (2005) A vaccine to prevent postherpetic neuralgia in older adults. N Engl J Med 352:2271–2284

    Article  CAS  PubMed  Google Scholar 

  38. Ragozzino MW, Melton LJ, Kurland LT (1982) Population-based study of herpes zoster and its sequelae. Medicine 61:310–316

    Article  CAS  PubMed  Google Scholar 

  39. Ragozzino MW, Melton RJ, Kurland LT (1982) Risk of cancer after herpes zoster: a population-based study. N Eng J Med 307:393–397

    Article  CAS  Google Scholar 

  40. Rowbotham MC, Davies PS, Verkempinck C et al (1996) Lidocaine patch: a double-blind comtrolled study of a new treatment for postherpetic neuralgia. Pain 65:39

    Article  CAS  PubMed  Google Scholar 

  41. Rowbotham MC, Goli V, Kunz NR et al (2004) Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double blind, placebo-controlled study. Pain 110:697–706

    Article  CAS  PubMed  Google Scholar 

  42. Rowbotham MC, Harden N, Stacey B et al (1998) Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 280(21):1837–1842

    Article  CAS  PubMed  Google Scholar 

  43. Saarto T, Wiffen PJ 2010 Antidepressants for neuropathic pain. The Cochrane Collaboration Issue (1):CD005454

    Google Scholar 

  44. Shapiro M, Kvern B, Watson CPN et al (2011) Update on herpes zoster vaccination: A family practioner’s guide. Can Fam Phys 57:1127–1132

    Google Scholar 

  45. Sindrup SH, Jensen TS (1999) Efficacy of pharmacological treatment of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83:389–400

    Article  CAS  PubMed  Google Scholar 

  46. Sindrup SH, Jensen T (2000) Pharmacological treatment of pain in polyneuropathy. Neurology 55:915–920

    Article  CAS  PubMed  Google Scholar 

  47. Sindrup SH, Bach FW, Madsen C et al (2003) Venlafaxine versus imipramine in painful polyneuropathy: a randomized controlled trial. Neurology 60:1284–1289

    Article  CAS  PubMed  Google Scholar 

  48. Van Wijck AJ, Opstelten W, Moore KG et al (2006) The PINE study of epidural steroids and local anesthetics to prevent postherpetic neuralgia: a randomized controlled trial. Lancet 367:219–224

    Article  CAS  PubMed  Google Scholar 

  49. Watson CPN, Morshead C, Van Der Kooy D et al (1988) Postherpetic neuralgia: postmortem analysis of a case. Pain 34:129–138

    Article  CAS  PubMed  Google Scholar 

  50. Watson CPN, Deck JH, Morshead C, Van der Kooy D, Evans RJ (1991) Postherpetic neuralgia: further postmortem studies of cases with and without pain. Pain 44:105–117

    Article  CAS  PubMed  Google Scholar 

  51. Watson CPN, Watt VR, Chipman M, Birkett N, Evans RJ (1991) The prognosis with postherpetic neuralgia. Pain 46:195–199

    Article  CAS  PubMed  Google Scholar 

  52. Watson CPN (2007) External validity of pharmaceutical trials in neuropathic pain. In: Rothwell PM (ed) The Lancet: treating individuals from randomized trials to personalized medicine. Elsevier, pp 121–130

    Google Scholar 

  53. Watson CPN, Gilron I, Sawynok J (2010) A qualitative, systematic review of head-to-head randomized, controlled trials of oral analgesics in neuropathic pain. J Pain Res Manage 15(3):147–157

    Article  Google Scholar 

  54. Watson CPN, Babul N (1998) Oxycodone relieves neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 50:1837–1841

    Article  CAS  PubMed  Google Scholar 

  55. Watson CPN, Vernich L, Chipman M, Reed K (1998) Amitriptyline versus nortriptyline in postherpetic neuralgia. Neurology 51:1166–1171

    Article  CAS  PubMed  Google Scholar 

  56. Watson CPN (2011) A death knell for codeine after craniotomy. Can Jnl Neur Sci 38(3):390–391

    Article  Google Scholar 

  57. Watson CPN, Midha R, Devor M, et al (2000) Trigeminal postherpetic neuralgia postmortem: clinically unilateral, pathologically bilateral. In: Devor M, Rowbotham MC, Wiesenfeld–Hallin Z (eds) Proceedings of the 9th world congress on pain

    Google Scholar 

  58. Watson CPN (2001) A tribute to R. Edgar Hope-Simpson, O.B.E., F.R.C.G.P. In: Watson CPN, Gershon A (eds) Herpes zoster and postherpetic neuralgia, Elsevier Science, B.V. Amsterdam, p xxiii

    Google Scholar 

  59. Watson CPN, Gilron I, Sawynok J, Lynch M (2011) Antidepressant analgesics and pain: are serotonin norepinephrine reuptake inhibitors any better? Pain 152:2206–2210

    Article  CAS  PubMed  Google Scholar 

  60. Whitley RJ, Weiss H, Gnann JW et al (1996) Acyclovir with and without prednisone for the treatment of herpes zoster. Ann Intern Med 125:376–383

    Article  CAS  PubMed  Google Scholar 

  61. Wiffen P, Collins S, McQuay H et al (2001) Anticonvulsant drugs for acute and chronic pain. (Cochrane review). The Cochrane library Issue 3 Oxford update software

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Peter N. Watson .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Watson, C.P.N. (2017). Postherpetic Neuralgia: Difficult to Treat, Easier to Prevent. In: Watson, C., Gershon, A., Oxman, M. (eds) Herpes Zoster: Postherpetic Neuralgia and Other Complications. Adis, Cham. https://doi.org/10.1007/978-3-319-44348-5_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-44348-5_19

  • Published:

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-44346-1

  • Online ISBN: 978-3-319-44348-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics